April 10th 2025
How can stakeholders prepare for changing therapy requirements?
April 9th 2025
Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.
A keynote presentation describes how supply chain visibility should rely on digital capabilities.
A panel discussion breaks down ways for stakeholders to meet temperature-controlled operational demands pertaining to product pipelines.
April 8th 2025
The conference’s opening keynote case study shares ways to elicit change that not only results in business growth and productivity, but a boost in patient connection as well.
United Cargo, DSV and Va-Q-Tec combine for frozen plasma delivery
Passive containers maintain a -20°C temperature spec
How to ensure conformance to EPCIS standards in drug traceability
Clinical trial data-gathering for Covid-19: new technology, new collaborations
TransCelerate opens up its network to qualified researchers; Oracle has a new platform
Sensitech upgrades its real-time cold-chain tracking capabilities
SensiWatch Platform includes analytics and APIs for integrating supply-chain information
Elpro introduces a real-time tracking system for cold chain shipments
Also: more innovative cold-chain actions during the Covid-19 pandemic
Latest round of UPS Healthcare Logistics expansions announced
1.3-million sq. ft to be added in the US and Europe
PRIMES: The six key elements of successful drug/device development
Guidance for companies starting out on the commercialization path
Cardinal Health tightens its relationship with Vineti, CGT software provider
Chain of identity, chain of custody are high priorities for autologous therapies
CSafe successfully pilots end-to-end tracking of its cold chain containers
Service can be multimodal and multi-provider, and is not device-dependent
World Courier fills a key gap in the race for Covid-19 treatment
California researchers needed to find a way to collaborate with their counterparts in Hong Kong
Operation Warp Speed expands governmental effort on vaccine, therapeutic and diagnostic countermeasures to Covid-19
Trump administration goal: ‘substantial quantities of a safe and effective vaccine available for Americans by January 2021’
More options for recyclable cold-chain containers
More packaging vendors are offering ‘curbside recyclable’ containers
The beginnings of a ‘Covid-19’ industry
Milken Institute survey finds nearly 300 therapies and vaccines
FDA loosens some DSCSA restrictions for the duration of the Covid-19 emergency
Strains are showing in drug supplies consumed in treating infected patients
Cold-chain service providers realign, expand
DuPont/Cold Chain Technologies in thermal blankets; va-Q-tec in shipment tracking; big bucks for SkyCell
Drone delivery of pharmaceuticals takes flight in Florida
UPS and CVS Pharmacy collaborate for direct-to-patient delivery; but check out Matternet, UPS’ drone partner
2020 Biopharma Cold Chain Sourcebook forecasts a $17.2-billion logistics market
Cellular and genetic therapies (CGTs) are a minor part of commercial business, but a growing part of research activity
Hospital pharmacy survey finds a lack of visibility to internal inventories
Kit Check data show value of track-and-trace technology, especially during the Covid-19 pandemic
The new normal in pharma and clinical trial logistics
Service providers are resetting their business practices to cope with the pandemic
Biotech developmental resources have a new brand: Cytiva
Now a Danaher Corp. asset, the former GE Healthcare Life Sciences business has been reshuffled
Milken Institute publishes a Covid-19 Tracker to monitor therapy development
As of March 26, 71 treatments and 47 vaccines are in development
Air cargo stutters, then responds to coronavirus pandemic
Passenger-based carriers are repurposing their flights
Pharma distributors adjust to the Covid-19 pandemic
Healthcare Ready pools industry efforts
DEA weighs in on Covid-19 response
DEA-registered practitioners can prescribe without an in-person interview
DHS national guidance: pharma distribution/logistics staff are ‘critical infrastructure workers’ during Covid-19 crisis
Guidance enables these workers to continue reporting to work
ARM assesses pace of cellular, genetic and tissue therapy development
But: the growth number of companies is exceeding the growth of trials
Pharma distribution adjusts to the coronavirus plague
The big question is how well will the system respond to spikes in demand, and lack of product
Real-world evidence gets closer to everyday treatment decisions
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data
‘Drugs to Watch’ list tags 11 about-to-be-approved therapies with blockbuster potential
Clarivate Analytics predicts both approvals and commercial potential
